Adebrelimab (SHR-1316)
Revision as of 23:33, 12 June 2022 by Jwarner (talk | contribs) (Created page with "Category:Drugs Category:Intravenous medications Category:T-cell activators Category:Anti-PD-L1 antibodies Category:Small cell lung cancer medications (inv...")